Leukos Biotech
PrivateLast Round
Debt
Oct 7, 2022
Total Funding Raised
$5.35M
Company Overview
Leukos Biotech operates in Healthcare & Life Sciences and is based in Barcelona. Its latest recorded funding round was a Debt round in October 2022.
Leukos Biotech is a biopharmaceutical company that develops innovative therapies and diagnostic tools for hematological malignancies and solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Leukos Biotech Comparables
Compare Leukos Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Oncostellae | 78% | |
| Pacylex Pharmaceuticals | 73% | |
| OneChain Immunotherapeutics | 73% |
For institutional investors. Book with your work email.
Leukos Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Oct 7, 2022 | ||||
| VC Round | Dec 31, 2018 | ||||
| Grant | May 1, 2018 | ||||
| Seed | Sep 21, 2016 | ||||
| Grant | Jan 1, 2016 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Leukos Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Union's Horizon Research and Innovation program | Grant |
| CDTI Innvierte | Seed |
| Ministerio de Economía, Comercio y Empresa | Grant |
| Inveready | VC Round, Seed |
| Spanish Government (Ministry of Science) | Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 7, 2022
$790K round from the Spanish Government.
- Sep 21, 2016
$4M round led by Inveready
For institutional investors. Book with your work email.
Leukos Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Leukos Biotech's valuation, stock price, and market status.
Is Leukos Biotech a public or private company?
Leukos Biotech is a private company.
What is the current stock price of Leukos Biotech?
Leukos Biotech is a private company, so its shares have no public market price. Caplight tracks Leukos Biotech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Leukos Biotech worth (valuation)?
Valuation information for Leukos Biotech is not publicly available.
Can I buy Leukos Biotech stock?
Leukos Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Leukos Biotech's last funding round?
Leukos Biotech's most recent funding round was Debt on October 7, 2022.
Who are the main investors in Leukos Biotech?
Key investors in Leukos Biotech include Inveready.
Will Leukos Biotech IPO soon?
No public IPO plans have been announced for Leukos Biotech.
How can I track Leukos Biotech secondary market activity?
Caplight tracks bids, offers, and trades in Leukos Biotech's shares on secondary markets.